Weil advised Aterian Investment Partners in its acquisition of Allentown, LLC, a provider of lab solutions serving the biomedical pre-clinical research and broader life sciences industries. The transaction closed on May 11, 2022.

The Weil team that advised Aterian Investment Partners was led by Private Equity partner Christopher Machera and included Private Equity associates Larissa Lucas, Charlotte Knutson, Pascale Nguyen (Admitted in Quebec Only) and Jace Krakovitz (Not Yet Admitted in New York). The European team included Paris Corporate Partner Emmanuelle Henry; Paris Corporate associates Adrien Coulaud and Pauline Tachi Duprat; Germany Corporate partner Barbara Jagersberger; Germany Corporate associates Madleen Düdder and Maximilian Schmitt; and London Private Equity associate Dominika Javornicka. The team also included Tax partner Jonathan Macke; Tax associate Andrew Lawson; Executive Compensation & Benefits partner Amy Rubin; Executive Compensation & Benefits associates Radhika Tahiliani and Nate Gross (Not Yet Admitted in New York); Technology & IP Transactions partner Dennis Adams; Technology & IP Transactions/Privacy associates Ruth Fisher, Audrey Nicolson, David Merck and Shannon Coffey; Banking & Finance partner Vynessa Nemunaitis; Banking & Finance associates Daniela Gutierrez and Richard Riles; Real Estate counsel Laura Murray; Real Estate associate Leah Fayssoux; Environmental Head Annemargaret Connolly; Environmental counsel Matthew Morton; Regulatory Transactions counsel John O'Loughlin, Timothy Welch and Nathan Cunningham; Antitrust counsel Michael Naughton; Antitrust associate Dan Nobil; Employment Litigation counsel Thomas Weatherill; and Employment Litigation associates Edward Dickinson and Elizabeth Casey.